Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy (Q77932308)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9927204%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

title

Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9927204%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

G Blandino

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9927204%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

A J Levine

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9927204%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

M Oren

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9927204%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

language of work or name

English

0 references

publication date

1 January 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9927204%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9927204%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9927204%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

477-485

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9927204%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9927204%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.onc.1202314

9 December 2019

exact match

0 references

cites work

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202314

7 January 2021

Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202314

7 January 2021

TP53 mutations and breast cancer prognosis: particularly poor survival rates for cases with mutations in the zinc-binding domains.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202314

7 January 2021

Modulation of activity of the promoter of the human MDR1 gene by Ras and p53.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202314

7 January 2021

Thymocyte apoptosis induced by p53-dependent and independent pathways.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202314

7 January 2021

p53 and treatment of bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202314

7 January 2021

Apoptosis in antitumor strategies: modulation of cell cycle or differentiation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202314

7 January 2021

Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202314

7 January 2021

Gain of function mutations in p53.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202314

7 January 2021

Apoptosis in cancer therapy: crossing the threshold

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202314

7 January 2021

Activation of c-myc gene expression by tumor-derived p53 mutants requires a discrete C-terminal domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202314

7 January 2021

An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202314

7 January 2021

The p53 gene is a potent determinant of chemosensitivity and radiosensitivity in gastric and colorectal cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202314

7 January 2021

p53; from inductive signal to cellular effect

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202314

7 January 2021

Induction of apoptosis in HeLa cells by trans-activation-deficient p53.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202314

7 January 2021

P53 gene alterations in human tumors: perspectives for cancer control.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202314

7 January 2021

'Gain of function' phenotype of tumor-derived mutant p53 requires the oligomerization/nonsequence-specific nucleic acid-binding domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202314

7 January 2021

p53, the cellular gatekeeper for growth and division

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202314

7 January 2021

Mutant p53 protein expression interferes with p53-independent apoptotic pathways.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202314

7 January 2021

A mutant p53 antagonizes the deregulated c-myc-mediated enhancement of apoptosis and decrease in leukemogenicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202314

7 January 2021

Cancer therapy and p53.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202314

7 January 2021

p53 is required for radiation-induced apoptosis in mouse thymocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202314

7 January 2021

Transcriptional activation of the human epidermal growth factor receptor promoter by human p53.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202314

7 January 2021

p53 protein overexpression and chemosensitivity in breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202314

7 January 2021

Ondansetron for intractable vertigo complicating acute brainstem disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202314

7 January 2021

p53 mutations: gains or losses?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202314

7 January 2021

Flexibility: the key to p53 function?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202314

7 January 2021

Expression of apoptosis-regulatory genes in lung tumour cell lines: relationship to p53 expression and relevance to acquired drug resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202314

7 January 2021

The polyproline region of p53 is required to activate apoptosis but not growth arrest.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202314

7 January 2021

Identification of a novel p53 functional domain that is necessary for efficient growth suppression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202314

7 January 2021

Reconstitution of p53 expression in a nonproducer Ab-MuLV-transformed cell line by transfection of a functional p53 gene.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202314

7 January 2021

Induction of cellular p53 activity by DNA-damaging agents and growth arrest.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202314

7 January 2021